Cancer experts from across the country gathered Friday, May 31, for UChicago Medicine's ASCO reception at the Chicago Architecture Center. Guests, including speakers Drs. Sonali Smith, Kunle Odunsi and Eileen Dolan, celebrated 50 years of University of Chicago Medicine Comprehensive Cancer Center's NCI designation and the breakthroughs achieved by researchers and clinicians along the way.
🧐 Cancer is more complicated than you think... Follow along as I dive into immunotherapy biomarkers, non-genetic cancer drivers, and the importance of the tumor-microenvironment (perivascular niche, anyone?) 👇 Check it out!
Cancer has many faces, some of which are only slowly revealing themselves. Work (https://lnkd.in/eRrzpkjd) by Panagiotis Karras, PhD, Ada Nowosad, Jean-Chris Marine, and colleagues at the VIB-KU Leuven Center for Cancer Biology pull back the mask on the role of non-genetic mechanisms and the tumor microenvironment in the development and metastasis of cancer. Want to know even more? Today is the last day to register for VIB's Immuno-Oncology conference!
Clinical studies are the gold standard of clinical research, and registry data is both difficult and not good enough. At Onkologisk Forum, Bettina Kulle Andreassen from the Cancer Registry of Norway tries to convince clinicians that they do not have to look at these two studies as two separate dogmas but that these two studies are both necessary to provide scientific evidence. In this MEDtalk, Bettina Kulle Andreassen further explains this aspect. #Cancer #OnkologiskForum2023
Hundreds of scientists, clinicians, students and community advocates gathered at the Science Museum of Virginia for Massey's 3rd annual Gordon Ginder Innovations in Cancer Symposium. The conference, moderated by Massey researchers Autumn Lanoye, Ph.D., and Can Senkal, Ph.D., featured a wide range of discussions and presentations on various topics around stress and cancer, including primary care perspectives on the correlation between stress and chronic health conditions like cancer; the molecular effects of various stressors on the genetic makeup of younger cancer patients; effective cognitive behavioral stress management strategies in cancer survivors; among many others. https://lnkd.in/ek8S_4-K
Ying Liu, MD, MPH, of Memorial Sloan Kettering Cancer Center, was awarded the FWC 2023-2024 Wilma Williams Education and Clinical Research Grant for Endometrial Cancer at this year's Annual Meeting. In this video interview, Dr. Liu elaborates on potential advancements in gynecologic cancer research, including her research that aims to utilize the microbiome and changes in therapies to identify women who would benefit most from additional treatments. Visit the link below to read the full article: https://bit.ly/4blM6Rb Through her mentorship, Dr. Liu hopes to instill a sense of possibility and empower aspiring gynecologic oncologists to pursue their dreams. “I hope that seeing someone like me receive a FWC grant will motivate future generations and show them that their dreams are possible too." #AAPIMonth #NationalCancerResearchMonth
By combining their training, experience, and research acumen with the power of real world data to publish new findings, oncologists like Ainhoa Madariaga and Luis Manso of Hospital 12 de Octubre help more cancer survivors than they will ever meet. Congratulations Drs. Madariaga and Manso on the selection of your research, "Association between endometriosis and ovarian cancer prognosis: A Real World Data Study" as one of the top four communications at the 2023 Congress of the Sociedad Española de Oncología Médica (SEOM). If you are attending, don't miss the Plenary Session presentation on Friday, September 22. See first comment for the link. #endometriosis #ovariancancer #realworlddata #realworldevidence #medicaloncology
Stay updated on cancer research breakthroughs, community and professional events and news. Subscribe to the University of Cincinnati Cancer Center newsletter to receive updates on the latest developments in cancer directly to your inbox. Join our mailing list: https://lnkd.in/gMPMXAtt #CancerResearch
Imaging plays an integral role in clinical trials, offering essential insights for researchers and sponsors. However, today's trial imaging data is severely underutilized. In this webinar, learn from a group of site stakeholders who have thoroughly examined the challenges within imaging workflows and successfully integrated high-value solutions. Register here ⇢ https://bit.ly/3PvcoYY Hear from panelists Jessica Moehle with Huntsman Cancer Institute, Dushyant Sahani with University of Washington, Rajan Gopalakrishnan with University of Chicago Medicine Comprehensive Cancer Center, and Michelle Liendo of VCU Massey Comprehensive Cancer Center, moderated by Jeffrey Sorenson with Yunu
As breast cancer research enters the age of AI, new innovations are shifting what it means to receive the diagnosis — with significant implications for individuals, researchers, governments and businesses. Thank you to the Toronto Star for shining a spotlight on the incredible work Breast Cancer Canada is doing with CEO Kimberly Carson at the helm. You can read more about PROgress Tracker, the Walk-a-Thon to Mother's Day, and why research matters at: https://bit.ly/3xoXHjp
Listen to a captivating conversation between Dr. Emil Lou, Associate Professor of Medicine at Masonic Cancer Center, University of Minnesota, and Dr. Chadi Nabhan, Chairman of Caris Precision Oncology Alliance™, about the intricate connections between pathogens and cancer. Tune in, gain valuable insights into the current landscape, and discover what the future holds for this dynamic intersection of science and medicine. https://ow.ly/OPqG50QtJvE
Listen to Episode 2 of the the Big Ten Cancer Research Consortium podcast, Bridging the Gap. Our Cancer Center member Ryan Nguyen, a UI Health medical oncologist, joined hosts Craig Cole, MD, of Michigan State University College of Human Medicine, Coral Omene, MD, PhD, of Rutgers Cancer Institute of New Jersey, and Monika Joshi, MD, MRCP, of PENN STATE MILTON S. HERSHEY MEDICAL CENTER, for an in-depth conversation on diversity in clinical trials. The group discussed a range of topics including barriers to equitable enrollment in clinical trials, the role of the FDA in promoting more diverse clinical trial enrollment, the role of precision oncology for diverse populations, findings from a clinical study on enrollment in trials leading to FDA approvals in breast cancer, community engagement in clinical trials, and the impact of lung cancer screening. https://bit.ly/3NfnvU8 #cancer #clinicaltrials #diversity #breastcancer #lungcancer
